Imagem da capa

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Na minha lista:
Publicado no:The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Autor principal: Pergola, Pablo E
Outros Autores: Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Publicado em:
Massachusetts Medical Society
Assuntos:
Akebia Therapeutics Inc
United States > US
Hemodialysis
Clinical trials
Hypoxia-inducible factors
Hemoglobin
Cerebral infarction
Collaboration
Kidney diseases
Heart failure
Hypoxia
Myocardial infarction
Confidence intervals
Erythropoietin
Thromboembolism
Drug dosages
Erythropoiesis
Patients
Hydroxylase
Anemia
Heart attacks
Prolyl hydroxylase
Design
Safety
Congestive heart failure
Dialysis
Acesso em linha:Citation/Abstract
Full Text
Full Text - PDF
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Seja o primeiro a partilhar um comentário!
Você deve entrar na sua conta antes